Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 4315 | 1732 | 54.8 | 94% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | RNA CARDIOVASC | Address | 17 | 100% | 0% | 8 |
| 2 | IMTTS | Address | 15 | 51% | 1% | 21 |
| 3 | MIR 133 | Author keyword | 14 | 60% | 1% | 15 |
| 4 | MICRORNA 1 | Author keyword | 13 | 58% | 1% | 15 |
| 5 | MIR 1 | Author keyword | 12 | 40% | 1% | 23 |
| 6 | MYOMIRS | Author keyword | 8 | 75% | 0% | 6 |
| 7 | CARDIOVASC REGENERAT | Address | 8 | 22% | 2% | 30 |
| 8 | MYOMIR | Author keyword | 6 | 71% | 0% | 5 |
| 9 | MOL TRANSLAT THER EUT STRATEGIES | Address | 6 | 30% | 1% | 17 |
| 10 | STATE PROV S BIOMED PHARMACEUT CHINA | Address | 6 | 19% | 2% | 26 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | MIR 133 | 14 | 60% | 1% | 15 | Search MIR+133 | Search MIR+133 |
| 2 | MICRORNA 1 | 13 | 58% | 1% | 15 | Search MICRORNA+1 | Search MICRORNA+1 |
| 3 | MIR 1 | 12 | 40% | 1% | 23 | Search MIR+1 | Search MIR+1 |
| 4 | MYOMIRS | 8 | 75% | 0% | 6 | Search MYOMIRS | Search MYOMIRS |
| 5 | MYOMIR | 6 | 71% | 0% | 5 | Search MYOMIR | Search MYOMIR |
| 6 | MIR 206 | 4 | 28% | 1% | 13 | Search MIR+206 | Search MIR+206 |
| 7 | MICRORNA 133 | 4 | 75% | 0% | 3 | Search MICRORNA+133 | Search MICRORNA+133 |
| 8 | MIR 208A | 4 | 75% | 0% | 3 | Search MIR+208A | Search MIR+208A |
| 9 | CIRCULATING MICRORNAS | 4 | 26% | 1% | 12 | Search CIRCULATING+MICRORNAS | Search CIRCULATING+MICRORNAS |
| 10 | MIR 208 | 3 | 57% | 0% | 4 | Search MIR+208 | Search MIR+208 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NEOINTIMAL LESION FORMATION | 155 | 81% | 5% | 95 |
| 2 | MUSCLE SPECIFIC MICRORNA | 103 | 63% | 6% | 103 |
| 3 | VASCULAR INTEGRITY | 53 | 38% | 6% | 112 |
| 4 | CIRCULATING MICRORNAS | 37 | 18% | 11% | 189 |
| 5 | MIR 206 | 32 | 55% | 2% | 41 |
| 6 | MIR 133 | 25 | 77% | 1% | 17 |
| 7 | CHANNEL GENES HCN2 | 23 | 86% | 1% | 12 |
| 8 | MUSCLE SPECIFIC MICRORNAS | 21 | 71% | 1% | 17 |
| 9 | ACUTE ENDURANCE EXERCISE | 15 | 88% | 0% | 7 |
| 10 | MIR 126 | 14 | 39% | 2% | 29 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| MicroRNAs in myocardial infarction | 2015 | 6 | 84 | 65% |
| MicroRNAs in cardiovascular disease: an introduction for clinicians | 2015 | 3 | 29 | 69% |
| Pervasive roles of microRNAs in cardiovascular biology | 2011 | 358 | 90 | 62% |
| MiR-206, a Key Modulator of Skeletal Muscle Development and Disease | 2015 | 3 | 58 | 59% |
| Circulating MicroRNAs Novel Biomarkers and Extracellular Communicators in Cardiovascular Disease? | 2012 | 181 | 67 | 37% |
| Non-coding RNAs in Cardiac Remodeling and Heart Failure | 2013 | 40 | 133 | 65% |
| microRNA Therapeutics in Cardiovascular Disease Models | 2014 | 14 | 83 | 60% |
| MicroRNA Regulation and Cardiac Calcium Signaling Role in Cardiac Disease and Therapeutic Potential | 2014 | 15 | 113 | 57% |
| Application of microRNAs in diagnosis and treatment of cardiovascular disease | 2015 | 2 | 154 | 44% |
| MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles | 2012 | 136 | 103 | 40% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | RNA CARDIOVASC | 17 | 100% | 0.5% | 8 |
| 2 | IMTTS | 15 | 51% | 1.2% | 21 |
| 3 | CARDIOVASC REGENERAT | 8 | 22% | 1.7% | 30 |
| 4 | MOL TRANSLAT THER EUT STRATEGIES | 6 | 30% | 1.0% | 17 |
| 5 | STATE PROV S BIOMED PHARMACEUT CHINA | 6 | 19% | 1.5% | 26 |
| 6 | KINGS BRITISH HEART FDN | 5 | 30% | 0.8% | 13 |
| 7 | MOL TRANSLAT THER EUT STRATEGIES IMTTS | 2 | 44% | 0.2% | 4 |
| 8 | COMPUTAT BIOMED SECT | 2 | 67% | 0.1% | 2 |
| 9 | EUROPEAN EXCELLENCE ATHEROSCLEROSIS HYPERTENS | 2 | 67% | 0.1% | 2 |
| 10 | IMMUNOL FUNCT GENOM | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000244606 | MARC RUTI BELL VASC BIOL DIS PROGRAM//MIR 33//ABCA1 PROTEIN |
| 2 | 0.0000226562 | MOL DIABET//GDD GED TOXICOL//HARVARD PROGRAM THER EUT SCI |
| 3 | 0.0000199209 | MIR 210//MICRORNA 210//C19MC |
| 4 | 0.0000145926 | GW182//DROSHA//ARGONAUTE |
| 5 | 0.0000126759 | MIR 140//MICRORNA 140//MICRORNA TARGET IDENTIFICATION |
| 6 | 0.0000105160 | MIR 155//MIR 146A//MIRNA 155 |
| 7 | 0.0000090728 | MICRORNA//MIR 21//MICRORNAS |
| 8 | 0.0000087085 | JR GRP SFB488//INTERDISZIPLINA ZENTRUM NEUROWISSEN//MIR137 |
| 9 | 0.0000081577 | MIR 122//MICRORNA 122//MIR 224 |
| 10 | 0.0000061106 | METABOLIC MEMORY//HYPERGLYCEMIC MEMORY//EPIGEN PROFILING IL |